Literature DB >> 19034017

Suppressive efficacy and proliferative capacity of human regulatory T cells in allogeneic and xenogeneic responses.

Yih-Jyh Lin1, Hidetaka Hara, Hao-Chih Tai, Cassandra Long, Daisuke Tokita, Peter Yeh, David Ayares, Adrian E Morelli, David K C Cooper.   

Abstract

BACKGROUND: An understanding of the mechanisms that suppress the human anti-pig cellular response is key for xenotransplantation. We have compared the ability of human regulatory T cells (Tregs) to suppress xenogeneic and allogeneic responses in vitro.
METHODS: Human peripheral blood mononuclear cells (PBMC), CD4+ T cells, or CD4+ CD25- T cells were stimulated with irradiated human or wild type (WT) or alpha1,3-galactosyltransferase gene-knockout (GT-KO) pig PBMC in the presence or absence of human CD4+ CD25 high Tregs. In separate experiments, 5- (and 6)-carboxyfluorescein diacetate succinimidyl ester-labeled human CD4+ T cells were stimulated with human or pig PBMC. The expansion and precursor frequencies of allo- and xenoreactive Tregs were assessed by labeling with FoxP3 mAb and flow cytometric analysis.
RESULTS: The responses of human PBMC, CD4+ T cells, and CD4+ CD25- T cells to pig PBMC were stronger than to human PBMC (P<0.05). Human anti-GT-KO responses were weaker than anti-WT responses (P<0.05). Human CD4+ CD25 high Tregs suppressed proliferation of CD4+ CD25- T cells to both human and pig PBMC stimulator cells with the same efficiency. Alloreactive CD4+ CD25+ FoxP3 high responder T cells proliferated more than their xenoreactive counterparts (P<0.05), although xenoreactive CD4+ CD25+ T cells proliferated more than alloreactive cells (P<0.05). There was no difference in precursor frequency between allo- and xeno-reactive CD4+ CD25+ FoxP3 high cells.
CONCLUSIONS: Human T-cell responses to pig cells are stronger than to allogeneic cells. The human response to GT-KO PBMC is weaker than to WT PBMC. Although human Tregs can suppress both responses, expansion of CD4+ CD25+ FoxP3 high cells against pig PBMC is weaker than against human PBMC. More human Tregs may be required to suppress the stronger xenogeneic response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034017      PMCID: PMC2629735          DOI: 10.1097/TP.0b013e318188acb0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  68 in total

1.  Tracking the immunoregulatory mechanisms active during allograft tolerance.

Authors:  Alberto Sánchez-Fueyo; Martina Weber; Christoph Domenig; Terry B Strom; Xin Xiao Zheng
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

2.  Analysis of human CD4 T lymphocyte proliferation induced by porcine lymphoblastoid B cell lines.

Authors:  Christine Bonenfant; Isabelle Vallée; Jishan Sun; Angélique Brossay; Gilles Thibault; Jean Maurice Guillaumin; Yvon Lebranchu; Pierre Bardos; J E Butler; Hervé Watier
Journal:  Xenotransplantation       Date:  2003-03       Impact factor: 3.907

Review 3.  Regulatory T cells in transplantation tolerance.

Authors:  Kathryn J Wood; Shimon Sakaguchi
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

Review 4.  Control of T-cell activation by CD4+ CD25+ suppressor T cells.

Authors:  E M Shevach; R S McHugh; C A Piccirillo; A M Thornton
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 5.  Clinical xenotransplantation: pigs might fly?

Authors:  Anthony Dorling
Journal:  Am J Transplant       Date:  2002-09       Impact factor: 8.086

Review 6.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

7.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

8.  Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse.

Authors:  Xiao-Chun Xu; Jeremy Goodman; Hitomi Sasaki; Jeffrey Lowell; T Mohanakumar
Journal:  Am J Transplant       Date:  2002-04       Impact factor: 8.086

9.  [Direct and indirect recognition in pig-to-man xenotransplantation].

Authors:  T Li; Y P Li; Z M Yang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  1999-11

10.  Identification of regulatory T cells in tolerated allografts.

Authors:  Luis Graca; Stephen P Cobbold; Herman Waldmann
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  25 in total

Review 1.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

2.  Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.

Authors:  Goutham Kumar; Hidetaka Hara; Cassandra Long; Humza Shaikh; David Ayares; David K C Cooper; Mohamed Ezzelarab
Journal:  Cytotherapy       Date:  2012-01-23       Impact factor: 5.414

Review 3.  Regulatory T-cell therapy in transplantation: moving to the clinic.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

4.  The effect of Gal expression on pig cells on the human T-cell xenoresponse.

Authors:  Tyler Wilhite; Corin Ezzelarab; Hidetaka Hara; Cassandra Long; David Ayares; David K C Cooper; Mohamed Ezzelarab
Journal:  Xenotransplantation       Date:  2012 Jan-Feb       Impact factor: 3.907

Review 5.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

6.  Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigs.

Authors:  H Iwase; B Ekser; V Satyananda; H Zhou; H Hara; P Bajona; M Wijkstrom; J K Bhama; C Long; M Veroux; Y Wang; Y Dai; C Phelps; D Ayares; M B Ezzelarab; D K C Cooper
Journal:  Transpl Immunol       Date:  2015-02-14       Impact factor: 1.708

7.  Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.

Authors:  Thomas M Savage; Brittany A Shonts; Aleksandar Obradovic; Susan Dewolf; Saiping Lau; Julien Zuber; Michael T Simpson; Erik Berglund; Jianing Fu; Suxiao Yang; Siu-Hong Ho; Qizhi Tang; Laurence A Turka; Yufeng Shen; Megan Sykes
Journal:  JCI Insight       Date:  2018-11-15

8.  Relative efficiency of porcine and human cytotoxic T-lymphocyte antigen 4 immunoglobulin in inhibiting human CD4+ T-cell responses co-stimulated by porcine and human B7 molecules.

Authors:  Tadatsura Koshika; Carol Phelps; Jason Fang; Seung Eun Lee; Minoru Fujita; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 9.  New concepts of immune modulation in xenotransplantation.

Authors:  Vikas Satyananda; Hidetaka Hara; Mohamed B Ezzelarab; Carol Phelps; David Ayares; David K C Cooper
Journal:  Transplantation       Date:  2013-12-15       Impact factor: 4.939

10.  Frankenswine, or bringing home the bacon: How close are we to clinical trials in xenotransplantation?

Authors:  David Kc Cooper
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.